On May 30, 2019 Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next-generation human enzymes to provide solutions for diseases with unmet medical need, reported that Anthony G. Quinn, M.B. Ch.B, Ph.D., president and chief executive officer of Aeglea, will participate in the following investor and industry conferences in June (Press release, Aeglea BioTherapeutics, MAY 30, 2019, View Source [SID1234536703]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2019 Healthcare Conference

Date:Wednesday, June 5, 2019

Presentation Time:8:30 a.m. ET

Location:New York, NY

Webcast:View Source

BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

Date:Tuesday, June 25, 2019

Presentation Time:11:40 a.m. ET

Location:New York, NY

Webcast:View Source

BIO International Convention

Date:Tuesday, June 4, 2019

Presentation Time:3:15 p.m. ET

Location:Philadelphia, PA